Related Experiment Videos
Assessing prognosis for high-grade soft-tissue sarcomas: search for a marker
X Q Li1, S G Parkekh, A E Rosenberg
1Orthopaedic Oncology Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Annals of Surgical Oncology
|November 1, 1996
Summary
Tumor size, not ploidy or location, is a key predictor of survival in high-grade soft-tissue sarcomas. This finding helps identify patients at higher risk for metastasis and guides treatment decisions for better outcomes.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Research
Background:
- Malignant soft-tissue tumors pose a significant challenge due to unpredictable distant metastasis.
- Despite advances in treatment, high-grade sarcomas have a high mortality rate exceeding 50%.
Purpose of the Study:
- To identify prognostic markers for metastasis and mortality in high-grade soft-tissue sarcomas.
- To evaluate the predictive value of tumor characteristics and ploidy analysis on patient outcomes.
Main Methods:
- Retrospective analysis of 93 patients with high-grade sarcomas treated between 1986 and 1992.
- Inclusion of tumor size, volume, and DNA ploidy (flow cytometry) data.
- Correlation of various factors with patient survival and metastasis risk.
Main Results:
- Tumor size (greatest diameter) and volume correlated with overall survival.
- Positive surgical margins also showed a correlation with survival.
- Lesion grade, sex, diagnosis, anatomical site, ploidic data, and treatment factors did not correlate with outcome.
Conclusions:
- Tumor size is a significant factor in predicting survival for soft-tissue sarcomas.
- Anatomical site, diagnosis, and ploidic analysis have limited value in anticipating patient outcomes.
- Further research may focus on refining the role of tumor size in risk stratification.